A Study to Evaluate Subjects With Turner Syndrome Treated With Growth Hormone
This study is a multicenter, open-label, observational, postmarketing surveillance study of Genentech growth hormone (GH) products in the treatment of girls with Turner syndrome in the United States and Canada.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Characterization of Subjects With Turner Syndrome Treated With Growth Hormone in the National Cooperative Growth Study (NCGS)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00097552
|Study Director:||Barbara Lippe, M.D.||Genentech, Inc.|